Skin-to-skin Contact in Healthy Term Infants (NCT06777524) | Clinical Trial Compass
RecruitingNot Applicable
Skin-to-skin Contact in Healthy Term Infants
South Korea130 participantsStarted 2025-02-10
Plain-language summary
This is a prospective, double-blind, randomized controlled clinical trial study to investigate short- and long-term effects of mother-infant skin-to-skin contact in healthy term infants, in order to provide supporting data for emphasizing mother-infant skin contact and family-centered care in South Korea.
Who can participate
Age range
1 Hour – 72 Hours
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Babies born at Korea University Anam Hospital
* Term infants (37 weeks or more)
* Infants with a birth weight of 2,500g or more
* Healthy infants with an Apgar score of 7 or higher at 5 minutes
* Mothers and infants without severe acute complications, such as requiring intensive care treatment immediately after delivery
Exclusion Criteria:
* Preterm infants born at 37 weeks of less gestation
* Low birth weight infants weighing less than 2500g at birth
* Mothers under the age of 20
* Unmarried mothers
* Multiple pregnancies (twins or triplets)
* Parents do not consent to participation in the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Percentage of any breast feeding (combined with formula and/or solid or not)